Xanax Addiction Withdrawal

What Is Xanax Withdrawal?

Xanax withdrawal is the set of physical and psychological symptoms that occur when a person who has developed dependence on alprazolam reduces or discontinues the drug. Withdrawal arises because chronic benzodiazepine use causes the brain to downregulate its GABA-A receptors and upregulate excitatory glutamate systems in an attempt to maintain neurochemical balance. When the drug is removed, this compensatory state produces a dangerous excitatory-inhibitory imbalance — the nervous system essentially loses its braking mechanism.

Alprazolam presents particularly challenging withdrawal characteristics compared to other benzodiazepines due to its high potency, rapid onset, and short half-life of 6–12 hours. This pharmacokinetic profile means that plasma levels drop quickly between doses, producing more abrupt neurological transitions and more severe withdrawal symptoms than longer-acting agents such as diazepam or clonazepam. Studies in Psychopharmacology have shown that short-acting benzodiazepine withdrawal produces symptom intensities 2–3 times greater than equivalent withdrawal from long-acting formulations.

Withdrawal severity is influenced by several factors: daily dose (higher doses produce more severe withdrawal), duration of use (longer use allows deeper neuroadaptation), rate of dose reduction (faster tapers produce worse symptoms), individual metabolism, age, concurrent substance use, and the presence of co-occurring psychiatric conditions.

The Xanax Withdrawal Timeline

Xanax withdrawal follows a generally predictable timeline, though individual variation is significant. Understanding the expected progression helps patients and families prepare for each phase and recognise when symptoms are following a normal course versus requiring additional medical attention.

Hours 6–24 — Early Withdrawal: Symptoms typically begin within 6–12 hours of the last dose, reflecting alprazolam’s short half-life. Initial symptoms include rebound anxiety (often more intense than the original anxiety disorder), insomnia, restlessness, irritability, and muscle tension. Heart rate and blood pressure may begin to rise.

Days 1–4 — Acute Withdrawal Onset: Symptoms intensify progressively. Anxiety escalates to near-panic levels, tremor develops (particularly in the hands), sweating and temperature dysregulation occur, nausea and vomiting may emerge, and perceptual disturbances such as heightened sensitivity to light, sound, and touch become apparent. Insomnia can become severe, with some individuals unable to sleep for 48–72 hours.

Days 5–14 — Peak Withdrawal: This is the most dangerous period. Symptoms reach maximum intensity, and the risk of seizure is highest between days 5 and 12. Additional symptoms at this stage may include visual or auditory hallucinations, depersonalisation, derealisation, severe cognitive impairment, and in the most serious cases, withdrawal delirium (a medical emergency requiring intensive care).

Weeks 3–8 — Gradual Resolution: Acute physical symptoms begin to subside, though anxiety, insomnia, mood instability, and cognitive difficulties persist. Many individuals experience a “window and wave” pattern — periods of relative normalcy (windows) interrupted by symptom flare-ups (waves) that gradually become less frequent and less intense.

Months 2–12+ — Protracted Withdrawal: A significant proportion of chronic benzodiazepine users experience protracted withdrawal syndrome, characterised by persistent anxiety, insomnia, cognitive fog, tinnitus, paraesthesias (tingling or burning sensations), and depressive symptoms that can last 6–18 months after complete cessation.

Physical Withdrawal Symptoms

The physical symptoms of Xanax withdrawal reflect the nervous system’s shift toward hyperexcitability after the removal of chronic GABAergic inhibition. These symptoms range from uncomfortable to medically dangerous.

Neurological symptoms are the most concerning and include seizures (generalised tonic-clonic seizures occurring in an estimated 20–30 percent of untreated abrupt withdrawal cases), tremor, myoclonus (involuntary muscle jerking), paraesthesias, headache, dizziness, and impaired coordination. Seizure risk is highest in individuals discontinuing doses above 4 mg daily, those with a history of epilepsy, and those withdrawing from concurrent alcohol or benzodiazepine use.

Autonomic symptoms include tachycardia, hypertension, profuse sweating, temperature dysregulation, nausea, vomiting, diarrhoea, and abdominal cramping. These reflect the sympathetic nervous system hyperactivity that accompanies GABA withdrawal.

Sensory disturbances are characteristic of benzodiazepine withdrawal and include hyperacusis (painful sensitivity to sound), photophobia (light sensitivity), hyperosmia (heightened sense of smell), and tactile hypersensitivity. Some individuals describe a sensation of the skin “crawling” or “burning” without external stimulus.

Psychological Withdrawal Symptoms

The psychological burden of Xanax withdrawal is often described by patients as more distressing than the physical symptoms. These symptoms arise from the combined effects of GABA depletion, glutamate excess, and disruption of serotonergic and dopaminergic systems.

Anxiety and panic during withdrawal can reach an intensity far beyond anything the individual experienced before starting Xanax. This rebound and withdrawal anxiety is neurochemically driven and does not reflect a permanent state — it resolves as GABA receptors gradually upregulate — but it can be devastating in the moment and is the single most common reason for relapse.

Depersonalisation and derealisation affect a significant minority of individuals and are among the most frightening withdrawal symptoms. The world appears unreal, distant, or dreamlike, and the sense of self feels fragmented or absent. These symptoms are temporary but can persist for weeks during acute withdrawal.

Cognitive dysfunction manifests as impaired concentration, memory difficulties, slowed thinking, and difficulty making decisions. These deficits reflect the brain’s transitional state as it relearns how to function without exogenous GABA enhancement.

Depression and suicidal ideation can emerge or intensify during withdrawal, particularly in individuals with pre-existing mood disorders. Close psychiatric monitoring throughout the withdrawal period is essential, with immediate intervention protocols available if suicidal thinking develops.

Medical Management of Xanax Withdrawal

Safe Xanax withdrawal requires a structured medical protocol. The gold standard is the Ashton Protocol, which involves converting the patient’s alprazolam dose to an equivalent dose of diazepam (a longer-acting benzodiazepine with a more gradual pharmacokinetic profile) and then tapering the diazepam dose by 5–10 percent every 1–2 weeks.

The diazepam conversion approach offers several advantages over direct alprazolam tapering: the long half-life of diazepam (20–100 hours including active metabolites) produces smoother plasma levels with fewer interdose fluctuations; the availability of multiple tablet strengths allows precise dose adjustments; and the slower elimination provides a natural “self-tapering” effect as drug levels decline gradually between doses.

Adjunctive medications used alongside the benzodiazepine taper include anticonvulsants (carbamazepine, gabapentin) for seizure prophylaxis and neuropathic symptom relief, beta-blockers (propranolol) for autonomic hyperarousal, antidepressants (SSRIs or mirtazapine) for emerging depression, and melatonin or trazodone for sleep support. Each adjunctive agent is selected based on the individual’s specific symptom profile and comorbidities.

Recovery and Long-Term Healing

Recovery from Xanax withdrawal is a gradual process of neurological healing. GABA-A receptors that have been downregulated by chronic benzodiazepine exposure require time to upregulate and return to normal function — a process that typically takes 6–18 months but continues to improve beyond that timeframe.

During this recovery period, ongoing therapeutic support is essential. CBT provides tools for managing residual anxiety without medication, while lifestyle interventions including regular exercise, nutritional optimisation, and sleep hygiene practices support the brain’s healing process. Patients are encouraged to view protracted symptoms not as evidence of permanent damage but as signs that neurological recovery is actively occurring.

At Phuket Island Rehab, our aftercare programme provides continued support through the protracted withdrawal phase, including regular check-ins with our medical team, ongoing psychotherapy access, and a supportive community of individuals navigating the same recovery journey. Our residential programme establishes the foundation — safe medical withdrawal, therapeutic skill-building, and lifestyle restructuring — and our aftercare ensures that foundation supports lasting recovery.

Frequently Asked Questions

Can Xanax withdrawal cause seizures?

Yes. Seizures are a well-documented and potentially fatal complication of benzodiazepine withdrawal, particularly with abrupt cessation or rapid dose reduction. The risk is highest in individuals taking doses above 4 mg daily for extended periods. Generalised tonic-clonic seizures typically occur between days 5 and 12 of withdrawal. This is why medically supervised tapering with anticonvulsant cover is essential.

How long does Xanax withdrawal last?

Acute withdrawal typically resolves within 2–4 weeks with a properly managed taper. However, protracted withdrawal symptoms — including anxiety, insomnia, cognitive fog, and perceptual disturbances — can persist for 3–18 months in chronic users. These protracted symptoms gradually diminish in frequency and intensity as the brain’s GABA systems fully recover.

Is Xanax withdrawal worse than opioid withdrawal?

The comparison depends on the metric. Opioid withdrawal is generally more acutely physically uncomfortable (severe pain, vomiting, diarrhoea) but is rarely fatal. Xanax withdrawal is less physically painful in the acute phase but carries genuine life-threatening risks including seizures and delirium. The protracted withdrawal phase of benzodiazepines is also typically longer and more psychologically challenging than opioid post-acute withdrawal.

What is the safest way to withdraw from Xanax?

The safest approach is a medically supervised gradual taper, ideally using the Ashton Protocol (conversion to diazepam followed by slow reduction). This method produces the most stable plasma levels, the lowest seizure risk, and the most manageable symptom profile. The taper should be individualised, with adjustments made based on the patient’s clinical response at each step.

Can I work during Xanax withdrawal?

During the acute withdrawal phase, most individuals find it difficult to maintain normal work obligations due to anxiety, cognitive impairment, and physical symptoms. This is one of the strongest arguments for residential treatment — it allows full focus on recovery without the additional stress of work demands. Those managing outpatient tapers may be able to continue working with accommodations, though this depends on withdrawal severity and job requirements.

Clinical Reviewer: Dr. Ponlawat Pitsuwan, Physician | Publisher: Phuket Island Rehab | Last Updated: April 2026 | Clinical Entities: Alprazolam Withdrawal, Benzodiazepine Withdrawal Seizures, GABA-A Receptor Upregulation, Ashton Protocol, Diazepam Conversion, Protracted Withdrawal Syndrome, Status Epilepticus, Withdrawal Delirium, Glutamate Hyperexcitability, Window and Wave Pattern